A Chinese surgical team has achieved a world first by transplanting a pig's liver and both kidneys simultaneously into a brain-dead human patient, marking a landmark advance in xenotransplantation research. The procedure, led by researchers from the Second Affiliated Hospital of Guangxi Medical University, was documented in the peer-reviewed journal Med on May 29, 2026. The milestone could reshape how the global medical community approaches chronic organ shortages.

What happened in the operating theatre

The recipient, a 53-year-old man who had suffered brain death, underwent the combined orthotopic transplant — meaning the pig organs were placed in the anatomically correct positions after his own organs were removed. Following the surgery, the transplanted liver and kidneys functioned inside the patient for nearly five days before the study was concluded at his family's request. The team described the operation as a proof-of-concept for multi-organ animal-to-human transplantation.

Why it matters

Xenotransplantation — the transfer of organs or tissues between different species — is increasingly viewed as a potential solution to the worldwide shortage of donor organs, which leaves thousands of patients on waiting lists or facing deteriorating health. 'This study provides initial evidence for the feasibility of pig-to-human orthotopic whole liver plus bilateral kidney transplantation,' the research team stated in their published paper. The findings are considered particularly significant because the liver presents far greater immunological and metabolic challenges than the kidney alone.

Immune and metabolic insights

Beyond the surgical feat itself, the team reported that the study identified early immune and metabolic features that could directly inform future clinical protocols. Organ rejection remains the central obstacle in xenotransplantation, and characterising the body's early response to multi-organ pig grafts is a critical step toward eventual human trials. The researchers noted these observations could guide modifications to both genetic engineering of donor pigs and post-operative immunosuppression regimens.

The competitive backdrop

The United States has been at the forefront of xenotransplantation research, with several American institutions having previously conducted single-organ pig kidney transplants into living patients. China's entry into multi-organ xenotransplantation signals a broadening of the global race to make animal-derived organs clinically viable. Genetically modified pigs — engineered to reduce human immune rejection — are central to research programmes across multiple countries.

What's next

The Guangxi Medical University team's paper is expected to prompt follow-up studies examining longer observation windows and refined immunosuppression strategies. Regulatory pathways for eventual living-patient trials remain a significant hurdle in both China and internationally. The field will be watching closely for whether this combined-organ approach can be replicated with extended organ survival and, ultimately, in non-brain-dead recipients.